Diabetes Care Devices - Africa | Statista Market Forecast

Revenue in the Diabetes Care Devices market market in Africa is projected to reach US$620.10m in 2024.
Revenue in this market is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 13.16%, leading to a market volume of US$1.15bn by 2029.
In a global context, the majority of revenue will be generated the United States, with an expected amount of US$11.71bn in 2024.
The diabetes care devices market in Africa is witnessing increased adoption of digital health technologies to improve patient outcomes and enhance remote monitoring capabilities.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Africa is witnessing considerable growth, driven by factors such as increasing prevalence of diabetes, rising healthcare investments, and enhanced accessibility to innovative monitoring technologies that empower patient management.

Customer preferences: Consumers in Africa are showing a growing preference for diabetes care devices that offer integrated digital solutions, such as apps that track glucose levels and provide personalized insights. This trend is fueled by a rising awareness of diabetes management and the importance of continuous monitoring. Additionally, younger demographics are increasingly adopting technology-driven health solutions, valuing convenience and real-time data access. Cultural shifts towards preventive healthcare are also influencing the demand for user-friendly devices that simplify diabetes management in daily life.

Trends in the market: In Africa, the Diabetes Care Devices Market is experiencing a notable shift towards integrated digital solutions, with a surge in demand for smart devices that sync with mobile applications to monitor glucose levels and deliver tailored insights. This trend is driven by increased health literacy and a proactive approach to diabetes management, particularly among younger populations keen on leveraging technology. The significance of this shift lies in its potential to enhance patient compliance and outcomes. For industry stakeholders, this presents opportunities for innovation and collaboration, as well as the need to address challenges related to infrastructure and accessibility in diverse markets.

Local special circumstances: In Africa, the Diabetes Care Devices Market is influenced by unique local factors, including diverse healthcare systems and varying levels of urbanization. In urban centers, improved access to technology has spurred the adoption of digital diabetes management tools, while rural regions face challenges related to connectivity and resource availability. Cultural perceptions of diabetes and health management also shape patient behaviors, with traditional beliefs impacting treatment adherence. Regulatory frameworks are evolving but can vary significantly, creating opportunities for localized innovations that cater to specific community needs.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Africa is significantly shaped by macroeconomic factors such as national economic stability, healthcare spending, and global supply chain dynamics. Countries experiencing economic growth are more likely to invest in healthcare infrastructure, facilitating the adoption of advanced diabetes management tools. Conversely, nations facing economic challenges may struggle with funding for medical devices, impacting access and availability. Additionally, global trends like the rise in diabetes prevalence and technological innovation drive demand for diabetes care solutions. Fiscal policies that promote health initiatives are crucial, as they can enhance affordability and accessibility for patients, particularly in underserved areas.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.